v3.26.3
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Series X
Preferred Stock
Series A-2
Preferred Stock
Series SA-2
Preferred Stock
Series A-1
Preferred Stock
Series A-1
Series A
Preferred Stock
Series A
Series Seed-2
Preferred Stock
Series Seed-2
Series Seed-1
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2023       $ 1 $ 31,542 $ (184) $ (33,397) $ (2,038)
Balance (in Shares) at Dec. 31, 2023 1,059,058   2,652,734   1,099,412   1,536,006 10,575,056        
Issuance of preferred stock, net of issuance costs       10,925 10,925
Issuance of preferred stock, net of issuance costs (in Shares) 1,610,103              
Issuance of Series A-2 preferred stock upon conversion of convertible notes       1,158 1,158
Issuance of Series A-2 preferred stock upon conversion of convertible notes (in Shares) 163,357              
Issuance of Series SA-2 preferred stock upon conversion of convertible notes       12,370 12,370
Issuance of Series SA-2 preferred stock upon conversion of convertible notes (in Shares) 1,745,625              
Stock options exercised       4 4
Stock options exercised (in Shares)       2,318        
Stock-based compensation expense       383 383
Foreign currency translation adjustment, net of taxes       (63) (63)
Net loss       (10,065) (10,065)
Balance at Dec. 31, 2024   $ 1 $ 56,382 $ (247) $ (43,462) $ 12,674
Balance (in Shares) at Dec. 31, 2024 1,773,460 1,745,625 1,059,058   2,652,734   1,099,412   1,536,006 10,577,374        
Issuance of preferred stock, net of issuance costs                            
Issuance of preferred stock, net of issuance costs (in Shares) 1,411,112   9,990 9,990
Stock options exercised                   $ 87     $ 87
Stock options exercised (in Shares)       92,217        
Stock-based compensation expense       1,603 1,603
Foreign currency translation adjustment, net of taxes       118 118
Net loss       (8,808) (8,808)
Balance at Sep. 30, 2025       $ 1 68,062 (129) (52,270) 15,664
Balance (in Shares) at Sep. 30, 2025 3,184,572 1,745,625 1,059,058   2,652,734   1,099,412   1,536,006 10,669,591        
Balance at Dec. 31, 2024   $ 1 56,382 (247) (43,462) 12,674
Balance (in Shares) at Dec. 31, 2024 1,773,460 1,745,625 1,059,058   2,652,734   1,099,412   1,536,006 10,577,374        
Issuance of preferred stock, net of issuance costs       9,990 9,990
Issuance of preferred stock, net of issuance costs (in Shares) 1,411,112              
Issuance of Series X preferred stock, net of $117 issuance costs       18,871 18,871
Issuance of Series X preferred stock, net of $117 issuance costs (in Shares) 769,114              
Stock options exercised       89 89
Stock options exercised (in Shares)       93,455        
Stock-based compensation expense       1,941 1,941
Foreign currency translation adjustment, net of taxes       118 118
Net loss       (12,199) (12,199)
Balance at Dec. 31, 2025       $ 1 $ 87,273 (129) (55,661) 31,484
Balance (in Shares) at Dec. 31, 2025 769,114 3,184,572 1,745,625 1,059,058   2,652,734   1,099,412   1,536,006 10,670,829        
Issuance of preferred stock, net of issuance costs                        
Issuance of preferred stock, net of issuance costs (in Shares) 10,126       257     257
Stock options exercised                 $ 92   $ 92    
Stock options exercised (in Shares)       85,271        
Vesting of restricted stock      
Vesting of restricted stock (in Shares)       82,276        
Stock-based compensation expense       1,421 1,421
Foreign currency translation adjustment, net of taxes       (18) (18)
Net loss       (14,327) (14,327)
Balance at Sep. 30, 2026       $ 1 $ 89,043 $ (147) $ (69,988) $ 18,909
Balance (in Shares) at Sep. 30, 2026 779,240 3,184,572 1,745,625 1,059,058   2,652,734   1,099,412   1,536,006 10,838,376